Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma

John R. Leyendecker, Mandip Gakhal, Khaled M. Elsayes, Ronan McDermott, Vamsidhar R. Narra, Jeffrey J. Brown

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVE: To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). SUBJECTS AND METHODS: Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. RESULTS: A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. CONCLUSION: No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.

Original languageEnglish (US)
Pages (from-to)178-184
Number of pages7
JournalJournal of Computer Assisted Tomography
Volume32
Issue number2
DOIs
StatePublished - Mar 1 2008

Fingerprint

Cholangiocarcinoma
Gadolinium
Portal Vein
Noise
Fats
Magnetic Resonance Imaging
Liver
Neoplasms
Surgical Pathology

Keywords

  • Cholangiocarcinoma
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma. / Leyendecker, John R.; Gakhal, Mandip; Elsayes, Khaled M.; McDermott, Ronan; Narra, Vamsidhar R.; Brown, Jeffrey J.

In: Journal of Computer Assisted Tomography, Vol. 32, No. 2, 01.03.2008, p. 178-184.

Research output: Contribution to journalArticle

Leyendecker, John R. ; Gakhal, Mandip ; Elsayes, Khaled M. ; McDermott, Ronan ; Narra, Vamsidhar R. ; Brown, Jeffrey J. / Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma. In: Journal of Computer Assisted Tomography. 2008 ; Vol. 32, No. 2. pp. 178-184.
@article{b5961dac2cd4413ba26e1ff388792ccb,
title = "Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma",
abstract = "OBJECTIVE: To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). SUBJECTS AND METHODS: Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. RESULTS: A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92{\%}, 67{\%}, 75{\%}, and 21{\%}; isointense in 8{\%}, 8{\%}, 17{\%}, and 12{\%}; and hyperintense in 0{\%}, 25{\%}, 8{\%}, and 67{\%} of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25{\%} of patients and the lowest in 33{\%}. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75{\%} of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38{\%} of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. CONCLUSION: No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.",
keywords = "Cholangiocarcinoma, Magnetic resonance imaging",
author = "Leyendecker, {John R.} and Mandip Gakhal and Elsayes, {Khaled M.} and Ronan McDermott and Narra, {Vamsidhar R.} and Brown, {Jeffrey J.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1097/RCT.0b013e31806bef8e",
language = "English (US)",
volume = "32",
pages = "178--184",
journal = "Journal of Computer Assisted Tomography",
issn = "0363-8715",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma

AU - Leyendecker, John R.

AU - Gakhal, Mandip

AU - Elsayes, Khaled M.

AU - McDermott, Ronan

AU - Narra, Vamsidhar R.

AU - Brown, Jeffrey J.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - OBJECTIVE: To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). SUBJECTS AND METHODS: Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. RESULTS: A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. CONCLUSION: No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.

AB - OBJECTIVE: To determine the enhancement phase providing the highest contrast-to-noise ratio (CNR) between cholangiocarcinoma and liver or portal vein on dynamic and delayed gadolinium-enhanced magnetic resonance imaging (MRI). SUBJECTS AND METHODS: Precontrast, 3-phase dynamic postcontrast, and delayed postcontrast MRI of the liver was performed in 25 patients with cholangiocarcinoma and correlated with surgical findings, pathology, and other imaging studies. Contrast-to-noise ratios for tumor relative to adjacent liver and portal vein were calculated from signal intensities determined from regions of interest obtained for each phase of enhancement. A subjective assessment of the signal intensity of the periportal tissues relative to the portal vein was made for each set of delayed images. RESULTS: A mass was visible in 24 of 25 patients. Tumor masses were hypointense in 92%, 67%, 75%, and 21%; isointense in 8%, 8%, 17%, and 12%; and hyperintense in 0%, 25%, 8%, and 67% of patients relative to liver on precontrast, arterial, portal venous, and delayed images, respectively. No single phase of gadolinium enhancement demonstrated consistently superior tumor-versus-liver CNR. Delayed imaging demonstrated the highest tumor-versus-liver CNR in 25% of patients and the lowest in 33%. The portal venous phase demonstrated the highest tumor-versus-portal vein CNR in 75% of patients. Delayed postcontrast images demonstrated the lowest tumor-versus-portal vein CNR in 38% of patients. Periportal tissues were isointense to portal vein in all but 1 patient on delayed images. CONCLUSION: No single phase of dynamic and delayed gadolinium-enhanced MRI demonstrates superior CNR between cholangiocarcinoma and normally enhancing liver, although the portal phase provides the best CNR between tumor and portal vein in most cases. Although delayed enhancement is typical of cholangiocarcinoma, delayed imaging does not necessarily offer superior contrast between tumor and liver parenchyma compared with other phases of enhancement. Differentiation between tumor and portal vein and periportal tissues may be difficult on delayed images.

KW - Cholangiocarcinoma

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=41749105330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749105330&partnerID=8YFLogxK

U2 - 10.1097/RCT.0b013e31806bef8e

DO - 10.1097/RCT.0b013e31806bef8e

M3 - Article

C2 - 18379298

AN - SCOPUS:41749105330

VL - 32

SP - 178

EP - 184

JO - Journal of Computer Assisted Tomography

JF - Journal of Computer Assisted Tomography

SN - 0363-8715

IS - 2

ER -